The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study

https://doi.org/10.1016/j.euroneuro.2016.07.003Get rights and content

Abstract

The concept of cognitive reserve (CR) suggests that the premorbid intelligence quotient (IQ), years of education and leisure activities provide more efficient cognitive networks and therefore allow a better management of some conditions associated to cognitive impairment.

Fifty-two DSM-IV diagnosed FEP subjects were matched with 41 healthy controls by age, gender and parental socio-economic status. All subjects were assessed clinically, neuropsychologically and functionally at baseline and after a two-year follow-up. To assess CR at baseline, three proxies have been integrated: premorbid IQ, years of education-occupation and leisure activities.

Higher CR was associated with better cognitive, functional and clinical outcomes at baseline. The CR proxy was able to predict working memory, attention, executive functioning, verbal memory and global composite cognitive score accounting for 48.9%, 19.1%, 16.9%, 10.8% and 14.9% respectively of the variance at two-year follow-up. CR was also significantly predictive of PANSS negative scale score (12.5%), FAST global score (13.4%) and GAF (13%) at two-year follow-up. In addition, CR behaved as a mediator of working memory (B=4.123) and executive function (B=3.298) at baseline and of working memory (B=5.034) at 2-year follow-up. An additional analysis was performed, in order to test whether this mediation could be attributed mainly to the premorbid IQ. We obtained that this measure was not enough by itself to explain this mediation.

CR may contribute to neuropsychological and functional outcome. Specific programs addressed to improve cognition and functioning conducted at the early stages of the illness may be helpful in order to prevent cognitive and functional decline.

Introduction

The concept of cognitive reserve (CR) refers to the ability of an adult brain to make flexible and efficient use of cognitive networks when performing tasks in the presence of brain pathology in order to minimize symptoms (Stern, 2002). Therefore, the CR can become a skill set that allows some people to actively offset the effects of the disease which might explain the fact that some individuals with similar brain pathology have a higher functioning than others (Stern, 2013). In the field of dementia it is hypothesized that the CR includes the capacity to withstand damage, ability to compensate for damage through the use of alternate networks, and remodeling and plasticity (Stern, 2006, Esiri and Chance, 2012). However, the concept of CR has not been accurately defined and has been characterized by different variables. The way to conceptualize a measure of CR remains open to debate. The most common proposed proxy indicators of CR includes years of educational attainment, occupation, leisure activities, and premorbid IQ (Barnett et al., 2006, Stern, 2009, de la Serna et al., 2013, Forcada et al., 2014). Among the indicators of CR, educational attainment may be the most widely studied and is most commonly used as definition of CR in previous studies, especially in dementia (Le Carret et al., 2005, Ngandu et al., 2007). The CR is primarily determined by genetic and neurodevelopmental factors, but may vary depending on the environment and exposure to certain factors such as education, lifestyle and mental and physical activities (Bora, 2015).

Different studies have shown that cognition can be considered a predictor of patients׳ outcome in schizophrenia (Green, 1996), finding a relationship between cognition and functional level (van Winkel et al., 2007). There have been attempts to associate CR with the clinical expression of the disease such as proposed in a study by Barnett et al. (2006) who found that the severity of symptoms for any given level of pathology would be greater for those individuals with low CR. Higher CR, in change, is normally associated with a later onset of psychosis, a positive moderator of the impact of psychosis on clinical outcomes, and having a greater capacity for reasoning and a greater insight (Leeson et al., 2011, Leeson et al., 2012). The latter has a significant impact on social functioning in schizophrenia. A recent study revealed that almost 70% of patients had deficits in their insight and more severe positive and negative symptoms at admission, worse functioning and worse adherence which was significantly associated with poorer insight (Schennach et al., 2012). Regarding cognition, in a sample of children and adolescents with FEP, the CR predicted performance in some cognitive domains such as attention and working memory at two-year follow-up (de la Serna et al., 2013).

It has not been shown that CR measures increase the effectiveness of interventions to improve cognitive functioning in schizophrenia (Kontis et al., 2013). However, in that study the cognitive reserve was defined only by premorbid measures such as premorbid IQ and vocabulary knowledge. Considering a broader view of CR including lifetime exposure to certain environmental factors like leisure activity, some authors have suggested that implementing interventions enhancing CR may minimize the decline on cognitive and psychosocial functioning in the future in mental disorders (Forcada et al., 2014, Anaya et al., 2016, Vieta and Torrent, 2015).

So far, studies of CR have focused primarily on patients with evolving chronic neurodegenerative conditions such Alzheimer disease, HIV, or multiple sclerosis (Vance et al., 2013, Boots et al., 2015, Martins Da Silva et al., 2015). The relevance of this paradigm to the clinical expression in psychiatric disorders remains poorly understood (Schneider et al., 2014). The aim of this study was to observe the predictability of CR in functional, clinical and cognitive measures at two years-follow up in an adult sample of subjects with FEP. We hypothesized that CR would predict cognitive, clinical and functional recovery in individuals with a FEP at two-year follow-up. Firstly, we expected to find a lower CR in patients with schizophrenia compared to healthy controls based on the neurodevelopmental hypothesis of schizophrenia, and secondly, we expected to find a more CR in those patients with good functional, clinical and cognitive outcomes.

Section snippets

Participants

For the present study we recruited a sample of 52 patients and 41 healthy controls (HC) through the Schizophrenia and the Bipolar Disorder Units at the Hospital Clinic of Barcelona.

The inclusion criteria for patients were: 1) diagnosis of a first psychotic episode; 2) age between 18–35 years old at the time of first evaluation; 3) presence of psychotic symptoms of less than 12 months׳ duration and 4) speak Spanish correctly. Exclusion criteria were: 1) mental Retardation according to DSM-IV

Sociodemographic characteristic of the sample

A total of 52 patients were enrolled in the study at baseline, and during the 2 year-follow-up 7 people discontinued (13.4%), particularly due to a loss of follow-up or refusing re-evaluation. There were no differences between patients and healthy subjects in terms of age, gender and socio-economic status, however we found significant differences in educational level and estimated premorbid IQ. The mean premorbid IQ was in the normal range in both groups, but the patients׳ was significantly

Discussion

The main finding of our study is that CR predicts baseline and long-term neuropsychological outcome, negative symptoms and functioning. In addition, our results show that CR has a mediator capacity.

At baseline, patients with a higher CR show a better cognitive, functional and clinical outcome. This result indicates that individual differences before illness onset can influence these variables, which is in line with previous studies addressing this association (Forcada et al., 2014).

In referring

Conflict of interest

MBe has been a consultant for, received grant/research support and honoraria from, and been on the speakers/advisory board of ABBiotics, Adamed, Boehringer, Eli Lilly, Ferrer, Forum Pharmaceuticals, Janssen-Cilag, Lundbeck, Otsuka, Pfizer and has obtained research funding from the Spanish Ministry of Health, the Spanish Ministry of Science and Education, the Spanish Ministry of Economy and Competiveness, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), by the Government of

Contributors

MBe, MBi and BC designed the study and wrote the protocol. EV contributed to the final design of the study. Authors MBi, BC, GM, BS and CT collected data. SA, CT and CMB performed the statistical analyses and analyzed the clinical data. SA and CT wrote the first version of the paper and the figures. All authors contributed to and have approved the final version of the paper.

Role of the funding Source

There was no explicit funding for the development of this study.

Acknowledgments

The authors of this study would like to acknowledge the support of Centro de Investigación Biomedica enRed de Salud Mental, Spain (CIBERSAM); the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya (2014SGR441 to the Barcelona Schizophrenia Unit and 2014SGR398 to the Bipolar Disorders Group) and the support of the Esther Koplowitz Centre (CEK). Dr. Carla Torrent is funded by the Spanish Ministry of Economy and Competitiveness, Instituto Carlos III, through a ‘Miguel

References (61)

  • G. Strauss et al.

    Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophrenia

    Schizophr. Res.

    (2012)
  • E. Tsapakis et al.

    Clinical management of negative symptoms of schizophrenia: An update

    Pharmacol. Ther.

    (2015)
  • L. Vesterager et al.

    Cognitive and clinical predictors of functional capacity in patients with first episode schizophrenia

    Schizophr. Res.

    (2012)
  • E. Vieta

    Staging and early intervention in bipolar disorder

    Lancet Psychiatry

    (2015)
  • C. Anaya et al.

    Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life psychosocial functioning and quality of life

    Acta Psychiatr. Scand.

    (2016)
  • C. Arango et al.

    Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders

    Schizophr. Bull.

    (2014)
  • A.P. Association

    Diagnostic and Statistical Manual of Mental Disorders

    (1994)
  • J. Barnett et al.

    Cognitive reserve in neuropsychiatry

    Psychol. Med

    (2006)
  • R. Baron et al.

    The moderator-mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations

    J. Pers. Social. Psychol.

    (1986)
  • M. Bernardo et al.

    Nuevos planteamientos clínicos en la esquizofrenia: los síntomas negativos

    (2014)
  • E. Boots et al.

    Occupational complexity and cognitive reserve in a middle-aged cohort at risk for alzheimer׳s disease

    Arch. Clin. Neuropsychol.

    (2015)
  • E. Bora

    Neurodevelopmental origin of cognitive impairment in schizophrenia

    Psychol. Med.

    (2015)
  • E. Bora et al.

    Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after the onset of pychosis?

    Schizophr. Bull.

    (2014)
  • V.P. Bozikas et al.

    Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature

    Aust. N. Z. J. Psychiatry

    (2011)
  • N.J. Breitborde et al.

    The Early Psychosis Intervention Center (EPICENTER): development and sic-month outcomes of an American first-episode psychosis clinical service

    BMC Psychiatry

    (2015)
  • H. Cannon-Spoor et al.

    Measurement of premorbid adjustment in chronic schizophrenia

    Schizophr. Bull.

    (1982)
  • M. Esiri et al.

    Cognitive reserve, cortical plasticity and resistance to Alzheimer׳s disease

    Alzheimers Res. Ther.

    (2012)
  • M. First et al.

    Structured clinical interview for DSM-IV Axis II Personality Disorders (SCID-II)

    (1997)
  • M. First et al.

    Structured clinical interview for DSM-IV axis I disorders-clinician (SCID-I)

    (1997)
  • I. Forcada et al.

    The influence of cognitive reserve on psychosocial and neuropsychological functioning in bipolar disorder

    Eur. Neuropsychopharmacol.

    (2014)
  • Cited by (81)

    • Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

      2023, European Neuropsychopharmacology
      Citation Excerpt :

      These toxic effects of relapse may be similar to the effects of cannabis use in FEP patients; in a previous study, a higher protective effect over clinical and functional outcomes was found in those patients who did not use cannabis (Amoretti et al., 2022). Our results regarding the association of higher CR with better cognitive functioning are in agreement with previous research (Amoretti et al., 2016; Amoretti et al., 2021b; Amoretti et al., 2020; de la Serna et al., 2013). Higher CR in FEP patients has been related to better outcomes in cognitive functioning in longitudinal studies.

    • Cognitive reserve profiles are associated with outcome in schizophrenia.

      2022, Journal of the Neurological Sciences
      Citation Excerpt :

      A Total Score, derived from the sum of all items is provided. Given the heterogeneity of the CR assessment, a “composite CR score” was computed for each subject through the three most commonly proposed proxy indicators of CR [15,19,22,24,41–44]: (1) crystallized intelligence, measured by the Verbal IQ score of the WAIS-R [45]; (2) education, assessed taking into account the number of years of education that participants completed [22]; (3) leisure activities, based on participants' lifetime participation in leisure, social and physical activities assessed by the Functioning Assessment Short Test [24]. All these proxies attempt to reflect premorbid brain usage [24].

    View all citing articles on Scopus
    View full text